Bilayer Therapeutics, Inc.
11:00 AM - 11:15 AM (EDT), Tuesday, June 6, 2023 ・ Session Room 104A
Development-stage company developing first-in-class therapeutics for the treatment of chronic constipation and other diseases of the colon such as metabolic disorder
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Massachusetts
Company HQ Country:
United States
Year Founded:
2020
Main Therapeutic Focus:
Gastrointestinal
Lead Product in Development:
BL-010 for the treatment of chronic idiopathic constipation (CIC)
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
